Skip to main content
Caplight Logo









SeaBeLife

SeaBeLife

Private
RoscoffHealthcare & Life Scienceshttps://www.seabelife.com/en/

Last Round

Early Funding

Oct 1, 2025

Total Funding Raised

$5.59M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

SeaBeLife is a biotechnology company that develops small-molecule therapies designed to protect tissues by simultaneously inhibiting necroptosis and ferroptosis, two regulated cell-death pathways.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverysmall-molecule therapeuticsnecroptosisferroptosiscell death inhibitionbiotech startupage-related macular degenerationAMDacute liver failuredual-inhibitor technologydrug licensingpreclinical developmentregenerative medicinepharma pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SeaBeLife Comparables

Compare SeaBeLife with similar companies based on industry and business-model similarity.

SeaBeLife comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Miramón Pharma S.L.
85%
FELIQS Corporation
81%
LinkGevity Limited
80%

SeaBeLife Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingOct 1, 2025
GrantApr 22, 2024
SeedSep 26, 2023

SeaBeLife Investors

Notable investors and investment history

SeaBeLife investors
InvestorRounds
Les Business Angels des Grandes ÉcolesSeed, Early Funding
WeLikeStartupEarly Funding
Angels SantéSeed, Early Funding
Femmes Business AngelsEarly Funding
ADEME - Agence de la transition écologiqueGrant
iXLife CapitalSeed, Early Funding
BpifranceGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 60% MoM.

  • Feb 10, 2026

    Grew 50% QoQ, from 10 to 15 employees.

SeaBeLife Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SeaBeLife Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SeaBeLife's valuation, stock price, and market status.

Firmographic Details

HeadquartersRoscoff
Employee Range14
Year Founded2019
Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?